Enhanced Safety Aesthetic Laser System

Status Not yet recruiting

Clinical Trial Summary

The purpose of this study is to determine whether a new laser system provides better safety and efficacy than existing lasers in popular cosmetic procedures such as hair removal, treatment of cosmetically disturbing vascular lesions and rhytides.

Clinical Trial Description

Cosmetic lasers are a well-established, popular modality for removal of unwanted hair, treatment of all types of vascular lesions, including hemangiomas, port wine stains, and a variety of telangiectases as well as facial rhytides reduction. The existing lasers are based on a wavelength that is specifically absorbed by the chromophore found in the target such as hair follicle, where the energy is converted to heat resulting in a thermal injury. However, the lasers for cosmetic treatments are not without limitations. A laser based long-term hair removal treatment is based on thermal destruction of the hair shaft and follicle using wavelengths that are specifically absorbed by the pigment melanin found in the hair follicle. The heating of hair follicle is done through heat dissipation from the hair shaft. One of the significant limitations of this approach is the fact that the epidermis through which the light energy must penetrate is rich in melanin and therefore absorbs a major portion of the energy, resulting in inadequate heating of the hair follicles. Similar problem exists when targeting other chromophores such as hemoglobin or water. The purpose of the study is an evaluation of safety and efficacy of a new laser based device. ;

Study Design

Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00495443
Study type	Interventional
Source	Scilex Ltd.
Contact	Alex Rapoport, BSC
Phone	972-39506949
Email	alecr@netvision.net.il
Status	Not yet recruiting
Phase	N/A
Start date	September 2007
Completion date	September 2008

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02103608` - Clinical Evaluation of Silk'n Glide for Face	N/A
Not yet recruiting	`NCT06003062` - Suppression of Upper Lip Hair Growth Using Novel Hemp Extract
Active, not recruiting	`NCT00145288` - Prospective Study of Patients With Hirsutism	Phase 2/Phase 3
Completed	`NCT00152048` - Evaluation of Eflornithine on Facial and Forearm Skin	Phase 4
Enrolling by invitation	`NCT01461694` - Facial Hair Reduction Using Intense Pulsed Light (IPL) & Alexandrite Laser	Phase 2/Phase 3
Not yet recruiting	`NCT00441948` - Enhanced Safety Laser Hair Removal System	N/A
Completed	`NCT03673995` - Myoinositol Plus L-tyrosine, Selenium and Chromium in PCOS	N/A
Recruiting	`NCT04979377` - Prevalence of Hyperandrogenism in Type 1 Diabetes
Completed	`NCT02494297` - DUS on the Prescribing Indications for CPA/EE in 5 European Countries
Completed	`NCT00960310` - Relative Bioavailability Study of Bicalutamide 50 mg Tablet and Casodex Following a 50 mg Dose in Healthy Subjects Under Fed Conditions	Phase 1
Completed	`NCT02793557` - Investigation of FOL-005 on Clinical Safety and Effect on Hair Growth	Phase 1/Phase 2
Completed	`NCT01555190` - Combination Therapy With Myo-inositol and Folic Acid Versus Myo-inositol Alone	N/A
Completed	`NCT01817894` - Treatment With Topical Eflornithin After Laser Treatment in Women With Facial Hirsutism	Phase 4
Completed	`NCT00143052` - Bone Status and Insulin Resistance in Hirsutism	N/A
Recruiting	`NCT01338519` - Database Study on Patients With PCOS	N/A
Recruiting	`NCT04292587` - Prevalence of Hirsutism in Turkey: Data of The Dermatoendocrinology Study Group
Completed	`NCT00959335` - Relative Bioavailability Study of Bicalutamide 50 mg Tablet and Casodex Following a 50 mg Dose in Healthy Subjects Under Fasting Conditions	Phase 1
Not yet recruiting	`NCT00371930` - Photodynamic Therapy for Permanent Hair Removal	Phase 1/Phase 2